Corvair vs PMcardio

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by Powerful Medical

AI Verdict

Both Corvair and PMcardio are AI-powered ECG analysis tools designed to assist healthcare professionals in interpreting ECGs for cardiac conditions. While Corvair focuses on 35 cardiac determinations and requires 4 ECG leads, PMcardio offers detection of over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, with additional features like visual AI explainability and flexible deployment options. The choice between them would depend on the specific range of conditions to be detected, desired deployment method, and the need for explainability features.

Choose Corvair if…

Choose Corvair if you are a healthcare professional in a clinical setting (e.g., cardiology, emergency medicine, internal medicine) and require an FDA-cleared AI ECG analysis system to assist in interpreting resting diagnostic ECGs. This tool is ideal for facilities that utilize standard diagnostic-bandwidth ECG recordings and need automated interpretation of 35 cardiac determinations (14 rhythm, 21 morphology) that can be reviewed, confirmed, edited, or deleted by an HCP.

View Corvair →

Choose PMcardio if…

Choose PMcardio if you are a healthcare professional, including paramedics, general practitioners, or emergency physicians, who need rapid, expert-level interpretation of ECGs for over 50 cardiac conditions at the point of care. This tool is particularly well-suited for mobile and web-based use, offering features like AI explainability with heatmaps (ECGxplain™) and detection of critical conditions like STEMI/OMI (Queen of Hearts™), even from photographed ECGs, to empower faster clinical decisions and improve care coordination.

View PMcardio →

When choosing between Corvair by AliveCor and PMcardio for AI-powered ECG analysis, physicians should consider their primary use case and desired level of diagnostic breadth. Corvair excels in providing a focused, FDA-cleared analysis of resting diagnostic ECGs, offering 35 cardiac determinations. It is designed to assist healthcare professionals in interpreting standard 10-second ECGs with a clear, reviewable automated interpretation. Its compatibility with standard diagnostic-bandwidth ECG recordings and requirement of only four leads make it a streamlined option for practices seeking a reliable, cleared tool for foundational ECG interpretation.

PMcardio, on the other hand, offers a broader diagnostic scope, interpreting ECGs to assess over 50 cardiac conditions, including specific detections like STEMI/OMI and reduced LVEF. A key practical difference is PMcardio’s deployment across mobile apps, web platforms, and enterprise integrations, alongside a freemium pricing model. This makes it highly accessible for clinicians needing rapid, expert-level interpretations at the point of care, potentially across various settings. Physicians prioritizing a wider range of detected conditions, mobile accessibility, and visual AI explainability (ECGxplain™) might find PMcardio more aligned with their needs, especially those in emergency medicine or settings requiring immediate, comprehensive insights. Corvair is better suited for those who value an FDA-cleared, focused tool for routine diagnostic ECG analysis within a more traditional clinical workflow.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Corvair PMcardio
Pricing Contact vendor Freemium
Deployment Cloud-based, Software as a Medical Device (SaMD) Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers deployment as a mobile app and web platform, making it highly accessible for individual clinicians. It also supports image recognition for printed ECGs, simplifying data input. Corvair is cloud-based SaMD, but its user interface and accessibility details are not as clearly articulated.

Clinical Value

PMcardio

PMcardio detects over 50 cardiac conditions, including advanced STEMI/OMI detection with AI explainability (heatmaps), and has been clinically validated in more than 25 studies. Corvair provides 35 cardiac determinations and is FDA-cleared, but the breadth of conditions and the extent of clinical validation appear less comprehensive than PMcardio's published claims.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model with a free plan for 5 ECG analyses per month and a clear pricing structure for individuals and teams. Corvair's pricing is listed as 'contact vendor,' which lacks transparency and makes it difficult to assess its value proposition without direct inquiry.

Enterprise Readiness

PMcardio

PMcardio explicitly highlights its enterprise-ready deployment, including integration with EHR/CVIS and EMS systems, role-based access control, SSO, and full audit trails. Corvair is cloud-based SaMD and HIPAA compliant, but specific enterprise integration features are not detailed in the provided information.

Innovation

PMcardio

PMcardio demonstrates strong innovation with its 'Queen of Hearts' STEMI/OMI detection, 'LVsense' for reduced LVEF detection, and 'ECGxplain' for visual AI explainability with heatmaps. Corvair's innovation lies in its 4-lead analysis for 35 determinations and ISO 42001 certification, but PMcardio's explainable AI and broader detection capabilities suggest a more advanced and transparent approach.

Support & Docs

Tie

Both tools are backed by established companies (AliveCor and Powerful Medical) that likely offer standard support and documentation. However, the provided information does not offer specific details to differentiate the quality or depth of support and documentation between Corvair and PMcardio, making a distinct winner impossible to determine.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Corvair PMcardio
Tool Name Corvair PMcardio
Company AliveCor Powerful Medical
Description FDA-cleared AI ECG analysis system that assists healthcare professionals in interpreting resting diagnostic ECGs with 35 cardiac determinations. CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately.
Regulatory Clearance FDA-cleared CE-certified
Number of Cardiac Determinations/Conditions 35 cardiac determinations (14 rhythm, 21 morphology) 50+ cardiac conditions (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders)
Key Features (Examples) Analyzes 10-second ECGs, Requires only 4 ECG leads for analysis, ISO 42001 certified AI Management System Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps

Videos

Demos, reviews, and walkthroughs featuring Corvair and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Corvair is a Software as a Medical Device (SaMD) that provides its capabilities as an Application Program Interface (API) library, allowing any compatible software or device to incorporate its ECG analytics. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, aiming to fit into existing workflows by capturing inputs, running relevant AI for clinical contexts, and coordinating downstream actions across an organization.
Corvair's performance is evaluated using standard ECG metrics like sensitivity, specificity, and positive predictive value against a known reference. PMcardio has been clinically validated in over 25 studies, demonstrating high sensitivity and specificity for major ECG abnormalities (86% and 92% respectively) and near-perfect accuracy for Atrial Fibrillation (97% sensitivity, 99% specificity). Its Queen of Hearts platform for STEMI detection showed 92% sensitivity and 81% specificity, outperforming standard processes.
PMcardio aims to ease the learning curve with a brief guide for digitizing ECGs, focusing on matching ECG pictograms to layouts and ensuring horizontal positioning of leads. While Corvair's documentation doesn't explicitly detail its learning curve, its API-based deployment suggests integration into existing systems, which could influence the user's direct interaction and learning needs.
Corvair provides 35 cardiac determinations, including 14 rhythm and 21 morphology determinations, assisting healthcare professionals in interpreting resting diagnostic ECGs. PMcardio detects over 50 ECG findings, including STEMI/OMI, reduced LVEF (LVsenseu2122), and offers visual AI explainability with heatmaps (ECGxplainu2122). It also provides guideline-adherent treatment recommendations based on clinical questions and a traffic-light triage system.
The provided information does not explicitly detail audit-trail features for Corvair. PMcardio's enterprise platform for organizations includes governance, role-based access, and workflow alignment, which typically encompass audit-trail capabilities, though specific features are not detailed.
PMcardio for Organizations is designed for multi-pathway, multi-site cardiac care delivery, offering interoperability, decision support, escalation, and outcomes intelligence in one platform. It connects to existing ECG systems, EHR/CVIS, and EMS systems, with governance and role-based access built-in. Corvair's API library deployment model suggests it can be integrated into various target devices and systems, which could facilitate multi-site rollouts depending on the integrating system's architecture.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.